American billionaires Susan and Henry Samueli announce donation to establish an institute that will look for new ways to treat cancer and create a better future for patients.
Beilinson Hospital in Petah Tikva.
Prof. Salomon Stemmer, Director of the Oncology Research Unit at Davidoff Center, Beilinson Hospital: “We found that there is a high enough level of antibodies to provide full protection for 90% of oncology patients undergoing active anti-cancer treatment.”
Israeli researchers have been examining the relationship between the COVID-19 vaccine (messenger RNA SARS-CoV-2) and patients undergoing treatment for various types of cancer.
The findings suggest that patients with cancer who are receiving active treatment and are at higher risk for severe COVID-19 disease, respond well to RNA SARS-CoV-2 vaccines, and that vaccination of these patients should be seriously considered. More than 90% of oncology patients have responded well to the vaccine.